Prevalence and distribution of beta-lactamase coding genes in third-generation cephalosporin-resistant Enterobacteriaceae from bloodstream infections in Cambodia

[1]  Y. Glupczynski,et al.  Validation of carbapenemase and extended-spectrum β-lactamase multiplex endpoint PCR assays according to ISO 15189. , 2013, The Journal of antimicrobial chemotherapy.

[2]  P. Hsueh,et al.  Distribution of Extended-Spectrum β-Lactamases, AmpC β-Lactamases, and Carbapenemases among Enterobacteriaceae Isolates Causing Intra-Abdominal Infections in the Asia-Pacific Region: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART) , 2013, Antimicrobial Agents and Chemotherapy.

[3]  L. Lynen,et al.  Bloodstream Infection among Adults in Phnom Penh, Cambodia: Key Pathogens and Resistance Patterns , 2013, PloS one.

[4]  J Jacobs,et al.  First National Workshop on Antibiotic Resistance in Cambodia: Phnom Penh, Cambodia, 16-18 November 2011. , 2013, Journal of global antimicrobial resistance.

[5]  P. Chaimanee,et al.  Risk factors and clinical outcomes of extended spectrum beta-lactamase (ESBL)-producing Escherichia coli septicemia at Srinagarind University Hospital, Thailand. , 2012, The Southeast Asian journal of tropical medicine and public health.

[6]  S. Park,et al.  Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15 , 2012, BMC Infectious Diseases.

[7]  G. Donelli,et al.  Characterization of Globally Spread Escherichia coli ST131 Isolates (1991 to 2010) , 2012, Antimicrobial Agents and Chemotherapy.

[8]  Hsing-Chun Chung,et al.  Bacteremia Caused by Extended-Spectrum-β-Lactamase-Producing Escherichia coli Sequence Type ST131 and Non-ST131 Clones: Comparison of Demographic Data, Clinical Features, and Mortality , 2011, Antimicrobial Agents and Chemotherapy.

[9]  P. Newton,et al.  Characteristics of CTX-M ESBL-producing Escherichia coli isolates from the Lao People's Democratic Republic, 2004–09 , 2011, The Journal of antimicrobial chemotherapy.

[10]  M. Kaku,et al.  Molecular characteristics of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae from the Philippines. , 2011, Acta tropica.

[11]  F. Aarestrup,et al.  Molecular Characterization and Antimicrobial Susceptibility Testing of Escherichia coli Isolates from Patients with Urinary Tract Infections in 20 Chinese Hospitals , 2011, Journal of Clinical Microbiology.

[12]  G. Peirano,et al.  Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. , 2010, International journal of antimicrobial agents.

[13]  E. Denamur,et al.  Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. , 2009, The Journal of antimicrobial chemotherapy.

[14]  J. Shu,et al.  A 7-year surveillance for ESBL-producing Escherichia coli and Klebsiella pneumoniae at a university hospital in Taiwan: the increase of CTX-M-15 in the ICU , 2009, Epidemiology and Infection.

[15]  F. Ariey,et al.  CTX-M β-Lactamases in Escherichia coli from Community-acquired Urinary Tract Infections, Cambodia , 2009, Emerging infectious diseases.

[16]  Y. Arakawa,et al.  Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread. , 2008, The Journal of antimicrobial chemotherapy.

[17]  F. Baquero,et al.  Dissemination of Clonally Related Escherichia coli Strains Expressing Extended-Spectrum β-Lactamase CTX-M-15 , 2008, Emerging infectious diseases.

[18]  J. Blanco,et al.  Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. , 2007, The Journal of antimicrobial chemotherapy.

[19]  Y. Carmeli,et al.  Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. , 2007, The Journal of antimicrobial chemotherapy.

[20]  A. Apisarnthanarak,et al.  Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study. , 2007, American journal of infection control.

[21]  V. Ensor,et al.  Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals. , 2006, The Journal of antimicrobial chemotherapy.

[22]  Yehuda Carmeli,et al.  Clinical and Economic Impact of Bacteremia with Extended- Spectrum-β-Lactamase-Producing Enterobacteriaceae , 2006, Antimicrobial Agents and Chemotherapy.

[23]  D. Church,et al.  Virulence Factors of Escherichia coli Isolates That Produce CTX-M-Type Extended-Spectrum β-Lactamases , 2005, Antimicrobial Agents and Chemotherapy.

[24]  D. Paterson.  "Collateral damage" from cephalosporin or quinolone antibiotic therapy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  Mitchell M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.

[26]  P. Courvalin,et al.  Distribution of Extended-Spectrum β-Lactamases in Clinical Isolates of Enterobacteriaceae in Vietnam , 2002, Antimicrobial Agents and Chemotherapy.

[27]  N. Hanson,et al.  Detection of Plasmid-Mediated AmpC β-Lactamase Genes in Clinical Isolates by Using Multiplex PCR , 2002, Journal of Clinical Microbiology.

[28]  D. Paterson,et al.  Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. , 2011, The Journal of antimicrobial chemotherapy.

[29]  P. Hawkey.  Prevalence and clonality of extended-spectrum beta-lactamases in Asia. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[30]  P. Hawkey.  Prevalence and clonality of extended-spectrum β-lactamases in Asia , 2008 .

[31]  Clinical,et al.  Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement , 2008 .

[32]  A. Apisarnthanarak,et al.  Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study. , 2007, American journal of infection control.